Párniczky Andrea, Kui Balázs, Szentesi Andrea, Balázs Anita, Szűcs Ákos, Mosztbacher Dóra, Czimmer József, Sarlós Patrícia, Bajor Judit, Gódi Szilárd, Vincze Áron, Illés Anita, Szabó Imre, Pár Gabriella, Takács Tamás, Czakó László, Szepes Zoltán, Rakonczay Zoltán, Izbéki Ferenc, Gervain Judit, Halász Adrienn, Novák János, Crai Stefan, Hritz István, Góg Csaba, Sümegi János, Golovics Petra, Varga Márta, Bod Barnabás, Hamvas József, Varga-Müller Mónika, Papp Zsuzsanna, Sahin-Tóth Miklós, Hegyi Péter
Heim Pál Children's Hospital, Budapest, Hungary.
First Department of Medicine, University of Szeged, Szeged, Hungary.
PLoS One. 2016 Oct 31;11(10):e0165309. doi: 10.1371/journal.pone.0165309. eCollection 2016.
The aim of this study was to analyse the clinical characteristics of acute pancreatitis (AP) in a prospectively collected, large, multicentre cohort and to validate the major recommendations in the IAP/APA evidence-based guidelines for the management of AP.
Eighty-six different clinical parameters were collected using an electronic clinical research form designed by the Hungarian Pancreatic Study Group.
600 adult patients diagnosed with AP were prospectively enrolled from 17 Hungarian centres over a two-year period from 1 January 2013.
With respect to aetiology, biliary and alcoholic pancreatitis represented the two most common forms of AP. The prevalence of biliary AP was higher in women, whereas alcoholic AP was more common in men. Hyperlipidaemia was a risk factor for severity, lack of serum enzyme elevation posed a risk for severe AP, and lack of abdominal pain at admission demonstrated a risk for mortality. Abdominal tenderness developed in all the patients with severe AP, while lack of abdominal tenderness was a favourable sign for mortality. Importantly, lung injury at admission was associated with mortality. With regard to laboratory parameters, white blood cell count and CRP were the two most sensitive indicators for severe AP. The most common local complication was peripancreatic fluid, whereas the most common distant organ failure in severe AP was lung injury. Deviation from the recommendations in the IAP/APA evidence-based guidelines on fluid replacement, enteral nutrition and timing of interventions increased severity and mortality.
Analysis of a large, nationwide, prospective cohort of AP cases allowed for the identification of important determinants of severity and mortality. Evidence-based guidelines should be observed rigorously to improve outcomes in AP.
本研究旨在分析前瞻性收集的大型多中心队列中急性胰腺炎(AP)的临床特征,并验证国际胰腺病协会(IAP)/美国胰腺协会(APA)关于AP管理的循证指南中的主要建议。
使用匈牙利胰腺研究小组设计的电子临床研究表格收集86项不同的临床参数。
2013年1月1日起的两年内,从匈牙利17个中心前瞻性纳入600例诊断为AP的成年患者。
在病因方面,胆源性和酒精性胰腺炎是AP最常见的两种形式。胆源性AP在女性中的患病率较高,而酒精性AP在男性中更为常见。高脂血症是病情严重程度的危险因素,血清酶未升高是重症AP的危险因素,入院时无腹痛提示有死亡风险。所有重症AP患者均出现腹部压痛,而无腹部压痛是死亡的有利征象。重要的是,入院时的肺损伤与死亡率相关。在实验室参数方面,白细胞计数和CRP是重症AP最敏感的两项指标。最常见的局部并发症是胰周积液,而重症AP最常见的远处器官衰竭是肺损伤。偏离IAP/APA循证指南中关于液体复苏、肠内营养和干预时机的建议会增加病情严重程度和死亡率。
对一个大型的、全国性的、前瞻性的AP病例队列进行分析,有助于确定病情严重程度和死亡率的重要决定因素。应严格遵循循证指南以改善AP的治疗结果。